Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

NIH Exec: Research Offers Opioid Crisis Solutions

The director of the National Institute on Drug Abuse says recent research in neuroscience and pharmacology reveals possible pathways out of the current epidemic of opioid addiction and overdose deaths. . . . → Read More: NIH Exec: Research Offers Opioid Crisis Solutions

Patents Awarded for Genetic Editing of CAR T-Cells

U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells. . . . → Read More: Patents Awarded for Genetic Editing of CAR T-Cells

Engineered Virus Shows Promise in Some Brain Tumors

A clinical trial testing a common virus modified to generate a specific immune response dramatically reduced deadly brain tumors in a small group of patients and extended their survival for years, but most other patients had only limited success. . . . → Read More: Engineered Virus Shows Promise in Some Brain Tumors

Report – Industry Pain, Addiction Drug Efforts Flagging

A report by a biotechnology industry organization says development efforts and financing for new drugs to treat pain and addiction are falling behind the health and safety needs of society. . . . → Read More: Report – Industry Pain, Addiction Drug Efforts Flagging

Biotechs Collaborate on Immunotherapies in $1.2B Deal

Two biotechnology companies developing cancer therapies harnessing the immune system are partnering on new treatments for solid tumor and blood-related cancers. . . . → Read More: Biotechs Collaborate on Immunotherapies in $1.2B Deal

Biotech, Univ. Lab Partner on Stem Cells for Alzheimer’s

A biotechnology company specializing in stem cell therapeutics is licensing a process from Texas A&M University to produce exosomes — cellular delivery packages — from adult stem cells as possible therapies for Alzheimer’s disease. . . . → Read More: Biotech, Univ. Lab Partner on Stem Cells for Alzheimer’s

Radiation, Biotech Companies Partner on Scar Therapy

Two companies taking different approaches to treating keloids — visible raised skin scars — are integrating their therapies to develop an anticipated treatment that removes and prevents the recurrence of these scars. . . . → Read More: Radiation, Biotech Companies Partner on Scar Therapy

Pharma Maker Crowdsourcing for Drug Delivery Partners

The global pharmaceutical company AstraZeneca is looking for collaborators to develop treatments for disease using nucleic acids delivered with cell-penetrating peptides. . . . → Read More: Pharma Maker Crowdsourcing for Drug Delivery Partners

Engineered T-Cells Show Extended Leukemia Remission

A clinical trial shows a patient’s immune system cells, modified to add cancer-fighting proteins, can extend high remission among children with a type of leukemia for as long as 12 months, but also with high rates of adverse effects. . . . → Read More: Engineered T-Cells Show Extended Leukemia Remission

Report: 19 New Precision Medicines Approved in 2017

A report on Food and Drug Administration approvals of new therapies says the agency is accelerating its reviews of treatments designed to address the specific molecular composition of individuals. . . . → Read More: Report: 19 New Precision Medicines Approved in 2017